At Dynamill, we deliver lean, high-touch trial execution, purpose-built for diagnostics and medical devices. Our model accelerates studies without sacrificing quality, giving sponsors speed, predictability, and confidence at every step.
With deep expertise in molecular diagnostics, AI-enabled technologies, and medical devices, we translate complex science into clear regulatory and clinical outcomes.
Fast. Predictable. Smart. Fast. Predictable. Smart. Fast. Predictable. Smart.
Fast. Predictable. Smart. Fast. Predictable. Smart. Fast. Predictable. Smart.
Diagnostics and devices demand more than a one-size-fits-all CRO approach. Sponsors face unique challenges: high-volume data, complex endpoints, accelerated timelines, and evolving FDA requirements.
That’s why Dynamill was purpose-built. We are not repurposed from pharma. We focus exclusively on clinical studies for diagnostics and devices, designed from the ground up to meet their unique demands. Our lean, high-touch model gives sponsors clarity and speed while delivering the evidence needed for FDA pathways including IDE, 510(k), PMA, and De Novo.
Our Guiding Principle
Clinical research is never just about data points. It is about designing studies that answer the right questions, protecting patients, and generating evidence that regulators trust.
Our guiding principle is simple:
Every study should move innovation forward with speed, integrity, and clarity.
Fast. Predictable. Smart.
Contact Us
+1877- DYNAMILL (3962 6455)
Our Location
16W285 83rd St. STE D-1 Burr Ridge, IL 60527
info@dynamillcro.com
Social Network